Expression of cyclin E in colorectal adenomas and adenocarcinomas: Correlation with expression of Ki-67 antigen and p53 protein

Virchows Archiv

Volumn 429, Issue 1, 1996, Pages 13-19

  Yasui, Wataru ^a   Kuniyasu, Hiroki ^a   Yokozaki, Hiroshi ^a   Semba, Shuho ^a   Shimamoto, Fumio ^b   Tahara, Eiichi ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^b HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Colorectal adenoma; Colorectal carcinoma; Cyclin E; Immunohistochemistry; Ki 67; p53

Indexed keywords

CYCLINE; PROTEIN P53; TUMOR ANTIGEN;

ADENOMA; ANTIGEN EXPRESSION; ARTICLE; CANCER STAGING; CARCINOGENESIS; CELL CYCLE; CELL PROLIFERATION; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCIDENCE; INTESTINE MUSCLE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBMUCOSA;

EID: 0029827478     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00196815     Document Type: Article

References (29)

1. Akama Y, Yasui W, Yokozaki H, Kuniyasu H, Kitahara K, Ishikawa T, Tahara E (1995) Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn J Cancer Res 86: 617-621
2. Ayhan A, Yasui W, Yokozaki H, Ito H, Tahara K (1992) Genetic abnormalities and expression of p53 in human colon carcinomas. Int J Oncol 1:431-437
3. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA, Sutherland RL (1993) Expression and amplification of cyclin genes in human breast cancer. Oncogene 8: 2127-2133
4. Dutta A, Chandra R, Leiter LM,Lester S (1995) Cyclins as markers of tumor proliferation: immunohistochemical studies in breast cancer. Proc Natl Acad Sci USA 92: 5386-5390
5. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer H, Kinzler KW, Vogelstein B (1993) WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825
6. INK4B is a potent effector of TGF-β induced cell cycle arrest. Nature 371: 257-261
7. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816
8. Heichman KA, Roberts JM (1994) Rules to replicate by. Cell 79: 557-562
9. Hunter T, Pines J (1994) Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age. Cell 79: 573-582
10. Japanese Research Society for Cancer of the Colon and Rectum (1994) General rules for clinical and pathological studies on cancer of the colon, rectum and anus, 5th edn. Kanehara, Tokyo
11. Jiang W, Kahn CM, Tomita N, Zhang Y-J, Lu SH, Weinstein IB (1992) Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 52: 2980-2983
12. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RSI, Johnson BE, Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436-440
13. Keyomarsi K, Pardee AB (1993) Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 90: 1112-1116
14. Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB (1994) Cyclin E, a potential prognostic marker for breast cancer. Cancer Res 54: 380-385
15. Kitahara K, Yasui W, Kuniyasu H, Yokozaki H, Akama Y, Yunotani S, Hisatsugu T, Tahara E (1995) Concurrent amplification of cyclin E and CDK2 genes in colorectal carcinomas. Int J Cancer 62: 25-28
16. MTSI gene status in human esophageal carcinoma cell lines. J Exp Ther Oncol 1: 7-12
17. Leach FS, Elledge SJ, Sherr CJ, Willson JK, Markowitz S, Kinzler KW, Vogelstein B (1993) Amplification of cyclin genes in colorectal carcinomas. Cancer Res 53: 1986-1989
18. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 368: 753-756
19. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A (1994) p27KIP1, a cyclin-Cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Gene Dev 8: 9-22
20. Schuuring E, Verhoeven E, Mooi WJ, Michalides RJAM (1992) Identification and cloning of two overexpressed genes. U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7: 355-361
21. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707
22. Sherr CJ (1994) G1 phase progression: cycling on cue. Cell 79: 515-555
23. Toyoshima H, Hunter T (1994) p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78: 67-74
24. Weidner N, Moore DH, Vartanian R (1994) Correlation of Ki67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody. Hum Pathol 25: 337-342
25. Xiong Y, Hannon G, Zhang H, Casso D, Kobayashi R, Beach D (1993) p21 is a universal inhibitor of cyclin kinases. Nature 366: 701-704
26. Yasui W, Ji Z-Q, Kuniyasu H, Ayhan A, Yokozaki H, Ito H, Tahara E (1992) Expression of transforming growth factor alpha in human tissues: immunohistochemical study and Northern blot analysis. Virchows Arch [A] 421: 513-519
27. Yasui W, Akama Y, Kuniyasu H, Yokozaki H, Samba S, Shimamoto F, Tahara E (1996) Expression of cyclin E in human gastric adenomas and adenocarcinomas: correlation with proliferative activity and p53 status. J Exp Ther Oncol 1:88-94
28. Yokozaki H, Kuniyasu H, Kitadai Y, Nishimura K, Todo H, Ayhan A, Yasui W, Ito H, Tahara E (1992) p53 point mutations in primary human gastric carcinomas. J Cancer Res Clin Oncol 119: 67-70
29. Yoshida K, Kawami H, Kuniyasu H, Nishiyama M, Yasui W, Hirai T, Toge T, Tahara E (1994) Coamplification of cyclin D. hst-1 and int-2 genes is a good biological marker of high malignancy for human esophageal carcinomas. Oncol Rep 1: 493-496